Please provide your email address to receive an email when new articles are posted on . Experiencing an acute COPD exacerbation raised the risk for acute cardiovascular events, such as a stroke or ...

Please provide your email address to receive an email when new articles are posted on . The likelihood for cardiovascular disease increased with impaired vs. normal spirometry findings. Individuals ...

A new study suggests that physicians might be able to assess the risk of major adverse cardiovascular events (MACE) in patients with chronic obstructive pulmonary disease (COPD) by analyzing right ...

Antonio Anzueto, MD, recently spoke with The American Journal of Managed Care® (AJMC®) about the latest advances in therapy for chronic obstructive pulmonary disease (COPD), as well as what is known ...

SAN ANTONIO — Long-acting antimuscarinic antagonists (LAMAs) do not increase the risk for cardiovascular events in patients with moderate to very severe chronic obstructive pulmonary disease (COPD), a ...

—Theses investigators found an increased risk for both individual and composite cardiovascular events following exacerbations of COPD, with sustained risk after 1 year regardless of severity. Reviewed ...

Triple therapy for COPD, vs ICS/LABA therapy, was independently associated with ischemic heart disease, heart failure, arrhythmia, and atrial fibrillation/flutter. Cardiovascular events in patients ...

The exacerbator group, which included more patients with diabetes, showed significant reductions in HbA1c, cholesterol, and urea levels after 8 weeks of rehabilitation. Pulmonary rehabilitation was ...

A higher pulmonary vascular resistance index during exercise, but not at rest, predicts poor clinical outcomes in adults with Fontan circulation, highlighting the value of invasive exercise testing.